Bristol-Myers Squibb Company BMY Price Prediction

The determination to procure Bristol-Myers Squibb Company is entirely contingent on your individualistic risk tolerance. As you may discern, Bristol-Myers Squibb Company's value has experienced an escalation of 0.01% during the preceding 24 hours, and Bristol-Myers Squibb Company has incurred a growth of 22.67% over the prior 30-day duration. Consequently, the determination of whether or not to invest in Bristol-Myers Squibb Company will hinge on whether such an investment aligns with your trading aspirations.

It appears that the mean value of Bristol-Myers Squibb Company may potentially surge to $67.13 by the end of this year. Looking at Bristol-Myers Squibb Company's prospects in a more extended five-year timeline, the stock could potentially growth to as much as $66.51. However, given the market's unpredictability, it is vital to conduct thorough research before investing any funds into a particular company or asset.

Based on the our new experimental Bristol-Myers Squibb Company forecast, the price of Bristol-Myers Squibb Company will fall by -0.17% over the next week and reach $56.42 by January 21, 2026.

Based on the our new experimental Bristol-Myers Squibb Company forecast, the price of Bristol-Myers Squibb Company will increase by 2.01% over the next month and reach $57.65 by February 13, 2026.

As per our most recent prediction on Bristol-Myers Squibb Company's value in 2026, BMY is anticipated to fluctuate within the range of $56.11 and $67.13. However, it is crucial to bear in mind that the stock market is exceptionally unstable, and this projected Bristol-Myers Squibb Company price forecast fails to consider sudden and extreme price fluctuations.

Bristol-Myers Squibb Company's future appears to be on an upward trend, with an maximum price of $66.51 projected after a period of five years. Based on the Bristol-Myers Squibb Company forecast for 2031, Bristol-Myers Squibb Company's value may potentially reach its highest peak of approximately $66.51, while its lowest peak is anticipated to be around $61.58.

Based on the our new experimental Bristol-Myers Squibb Company price prediction simulation, BMY’s value in 2026 expected to grow by 18.8% to $67.13 if the best happened. The price will be between $67.13 and $56.11 during 2026.

According to our latest experimental simulation for Bristol-Myers Squibb Company price prediction, BMY’s value could rise by 23.33% to $69.70 in 2027, assuming the most favorable conditions. The price is projected to fluctuate between $69.70 and $60.54 throughout the year.

Our new experimental Bristol-Myers Squibb Company price prediction model suggests that BMY’s value in 2028 could increase by 11.34% , reaching $62.92 in the best-case scenario. The price is expected to range between $62.92 and $51.09 during the year.

Based on our experimental forecast model, Bristol-Myers Squibb Company's value may experience a 2.06% growth in 2029, potentially reaching $57.67 under optimal conditions. The predicted price range for 2029 lies between $57.67 and $51.15.

Using our new experimental simulation for Bristol-Myers Squibb Company price predictions, BMY’s value in 2030 is expected to rise by 13.77% , reaching $64.29 in the best scenario. The price is forecasted to range between $64.29 and $54.03 over the course of 2030.

Our experimental simulation indicates that Bristol-Myers Squibb Company’s price could grow by 17.69% in 2031, potentially hitting $66.51 under ideal conditions. The price will likely fluctuate between $66.51 and $61.58 during the year.

Based on the findings from our latest experimental Bristol-Myers Squibb Company price prediction, BMY could see a 31.14% rise in value, reaching $74.11 if the most positive scenario plays out in 2032. The price is expected to stay within a range of $74.11 and $65.37 throughout the year.

According to our experimental Bristol-Myers Squibb Company price prediction, BMY’s value is anticipated to rise by 51.01% in 2033, with the highest potential price being $85.34. Throughout the year, BMY’s price could range from $85.34 and $74.29.

The results from our new Bristol-Myers Squibb Company price prediction simulation suggest that BMY may rise by 65.71% in 2034, potentially reaching $93.64 under the best circumstances. The predicted price range for the year is between $93.64 and $83.08.

Based on our experimental forecast for Bristol-Myers Squibb Company’s price, BMY could grow by 90.08% , with the value potentially hitting $107.42 in 2035. The expected price range for the year lies between $107.42 and $90.11.

Our recent Bristol-Myers Squibb Company price prediction simulation suggests that BMY’s value might rise by 134.44% in 2036, possibly reaching $132.49 if conditions are optimal. The expected price range for 2036 is between $132.49 and $104.03.

According to the experimental simulation, Bristol-Myers Squibb Company’s value could rise by 173.03% in 2037, with a high of $154.30 under favorable conditions. The price is expected to fall between $154.30 and $128.81 over the course of the year.